Call for evidence outcome

Medicines and Medical Devices Act Call for Evidence

This call for evidence has closed

Read the full outcome

Detail of outcome

The purpose of the MMD Act call for evidence for veterinary medicines was to gain insight into every aspect of the veterinary medicines supply chain and to understand whether the MMD Act allowed the VMD to keep the VMR up-to-date and fit-for-purpose to protect animal health, public health and the environment.

This summary reflects responses from individual stakeholders and organisations, covering a wide area of the veterinary medicines sector across England, Wales, Scotland and Northern Ireland, as well as responses from stakeholders representing international organisations.

Based on the 78 responses received, stakeholders appear supportive of minor changes to the MMD Act, but a major restructure could be unnecessary.


Original call for evidence

Summary

The Veterinary Medicines Directorate is seeking views from stakeholders to inform future reform of the UK’s veterinary medicines regulatory framework.

This call for evidence ran from
to

Call for evidence description

The purpose of this review is to evaluate whether the legislation is operating as intended now, if it continues to effectively protect animal and public health and the environment, and avoids imposing unnecessary or excessive regulatory burdens. The review is also looking at the structure of the legislation and whether restructure or consolidation would make the regulations clearer or easier to implement.

We would value your views and experiences on the Veterinary Medicines Regulations 2013 (as amended) which are relevant to you or your organisation. Please provide us with unbiased responses and where possible, specific examples.

Updates to this page

Published 1 September 2025

Sign up for emails or print this page